(“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding Matt Stang, Co-founder and CEO of Delic, and his participation at the Sequire Cannabis and Psychedelic Conference and the Scottsdale Capital Event.
- Sequire Cannabis and Psychedelic Conference
April 20, 2022
Hosted by Sequire, the virtual event will bring together over 50 leading public companies in the cannabis, CBD, and psychedelic space to discuss the future of their respective industries. Stang will not only present the Company’s performance and industry outlook but also participate in one-on-one meetings with investors. To register for this year’s conference, please visit https://cannabis-conference22.mysequire.com. - Scottsdale Capital Event
April 22-24, 2022
Located in Scottsdale, Arizona, the three-day conference includes scheduled meetings and networking events with growing companies and financiers. Stang will participate in one-on-one meetings that examine the Company’s strategic outlook for the remainder of the year. To learn more about the Scottsdale Capital Event, please visit https://cem.ca/conference/scottsdale-capital-event-2022.
Got a Questions?
Find us on Socials or Contact us and we’ll get back to you as soon as possible.